IP Library Granted Patent US 9,770,431
Granted Patent B2
US 9,770,431 · App. 15/041,960 · Granted Sep 26, 2017

Tiglien-3-one derivatives

Inventors: Paul Warren Reddell (Yungaburra, AU); Victoria Anne Gordon (Yungaburra, AU)
Assignee: QBiotics Limited
A61K31/336A01N43/20A01N43/90A01N45/00A01N53/00C07D301/32C07D303/14C07D303/17C07D303/32C07D303/44C07D493/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,770,431
App. No.
15/041,960
Granted
Sep 26, 2017
Kind
B2
Abstract

The present invention relates to tiglien-3-one compounds and their use in methods of treating or preventing protozoal infections, bacterial infections, parasitic infections and cell proliferative disorders. The tiglien-3-one compounds are also used in methods of controlling pests in humans, animals, plants and the environment.

Claims (77)

1. A method of treating a bacterial or nematode infection comprising administering to a subject in need thereof a compound of formula (II):

wherein:

X is —O—, —S— or —NR 25 —;

R 1 and R 2 are each independently hydrogen, —OH, —OC 1 -C 10 alkyl, —OC 2 -C 10 alkenyl, —OC 2 -C 10 alkynyl, —Ocycloalkyl, —OC(O)C 1 -C 10 alkyl, —OC(O)C 2 -C 10 alkenyl, —OC(O)C 2 -C 10 alkynyl, —OC(O)cycloalkyl, —OC(O)heterocyclyl, —OC(O)heteroaryl, —OC(O)NHC 1 -C 10 alkyl, —OC(O)NHC 2 -C 10 alkenyl, —OC(O)NHC 2 -C 10 alkynyl, —OC(O)NHcycloalkyl, —OC(O)NHaryl, —OC(O)NHheterocyclyl, —OC(O)NHheteroaryl, —OC(S)NHC 1 -C 10 alkyl, —OC(S)NHC 2 -C 10 alkenyl, —OC(S)NHC 2 -C 10 alkynyl, —OC(S)NHcycloalkyl, —OC(S)NHaryl, —OC(S)NHheterocyclyl, —OC(S)NHheteroaryl or R 1 and R 2 taken together are ═O, ═S, ═NH or ═N(C 1 -C 6 alkyl);

R 3 is hydrogen, —C 1 -C 10 alkyl, —C 2 -C 10 alkenyl or —C 2 -C 10 alkynyl;

R 4 and R 5 are each independently hydrogen, —C 1 -C 10 alkyl, —C 2 -C 10 alkenyl, —C 2 -C 10 alkynyl, —OH, —OC 1 -C 10 alkyl, —OC 2 -C 10 alkenyl, —OC 2 -C 10 alkynyl, —Ocycloalkyl, —OC(O)C 1 -C 10 alkyl, —OC(O)C 2 -C 10 alkenyl, —OC(O)C 2 -C 10 alkynyl, —OC(O)cycloalkyl, —OC(O)aryl, —OC(O)heterocyclyl, —OC(O)heteroaryl, —OC(O)NHC 1 -C 10 alkyl, —OC(O)NHC 2 -C 10 alkenyl, —OC(O)NHC 2 -C 10 alkynyl, —OC(O)NHcycloalkyl, —OC(O)NHaryl, —OC(O)NHheterocyclyl, —OC(O)NHheteroaryl, —OC(S)NHC 1 -C 10 alkyl, —OC(S)NHC 2 -C 10 alkenyl, —OC(S)NHC 2 -C 10 alkynyl, —OC(S)NHcycloalkyl, —OC(S)NHaryl, —OC(S)NHheterocyclyl, —OC(S)NHheteroaryl, F, Cl, Br, I, —CN, —NO 2 or N(R 25 ) 2 ;

or R 4 and R 5 taken together form a double bond or are —O—, —S—, —NR 25 — or —CR 26 R 27 —;

R 6 is hydrogen, —C 1 -C 10 alkyl, —C 2 -C 10 alkenyl or —C 2 -C 10 alkynyl;

R 8 is hydrogen, —C 1 -C 10 alkyl, —C 2 -C 10 alkenyl or —C 2 -C 10 alkynyl;

R 10 is hydrogen, —C 1 -C 10 alkyl, —C 2 -C 10 alkenyl or —C 2 -C 10 alkynyl;

R 11 is —OH, —OC 1 -C 20 alkyl, —OC 2 -C 20 alkenyl, —OC 2 -C 20 alkynyl, —Ocycloalkyl, —OC(O)C 1 -C 20 alkyl, —OC(O)C 2 -C 20 alkenyl, —OC(O)C 2 -C 20 alkynyl, —OC(O)cycloalkyl, —OC(O)aryl, —OC(O)heterocyclyl, —OC(O)heteroaryl, —OC(O)NHC 1 -C 20 alkyl, —OC(O)NHC 2 -C 20 alkenyl, —OC(O)NHC 2 -C 20 alkynyl, —OC(O)NHcycloalkyl, —OC(O)NHaryl, —OC(O)NHheterocyclyl, —OC(O)NHheteroaryl, —OC(S)NHC 1 -C 20 alkyl, —OC(S)NHC 2 -C 20 alkenyl, —OC(S)NHC 2 -C 20 alkynyl, —OC(S)NHcycloalkyl, —OC(S)NHaryl, —OC(S)NHheterocyclyl, or —OC(S)NHheteroaryl;

or R 10 and R 11 taken together form a carbonyl group (═O);

R 12 is —OH, —OC 1 -C 20 alkyl, —OC 2 -C 20 alkenyl, —OC 2 -C 20 alkynyl, —Ocycloalkyl, —OC(O)C 1 -C 20 alkyl, —OC(O)C 2 -C 20 alkenyl, —OC(O)C 2 -C 20 alkynyl, —OC(O)cycloalkyl, —OC(O)aryl, —OC(O)heterocyclyl, —OC(O)heteroaryl, —OC(O)NHC 1 -C 20 alkyl, —OC(O)NHC 2 -C 20 alkenyl, —OC(O)NHC 2 -C 20 alkynyl, —OC(O)NHcycloalkyl, —OC(O)NHaryl, —OC(O)NHheterocyclyl, —OC(O)NHheteroaryl, —OC(S)NHC 1 -C 20 alkyl, —OC(S)NHC 2 -C 20 alkenyl, —OC(S)NHC 2 -C 20 alkynyl, —OC(S)NHcycloalkyl, —OC(S)NHaryl, —OC(S)NHheterocyclyl, or —OC(S)NHheteroaryl;

R 13 and R 14 are each independently hydrogen or —C 1 -C 10 alkyl;

R 18 is C 1 -C 20 alkyl, —C 2 -C 20 alkenyl, —C 2 -C 20 alkynyl, —OH, —OC 1 -C 20 alkyl, —OC 2 -C 20 alkenyl, —OC 2 -C 20 alkynyl, —Ocycloalkyl, —OC(O)C 1 -C 20 alkyl, —OC(O)C 2 -C 20 alkenyl, —OC(O)C 2 -C 20 alkynyl, —OC(O)cycloalkyl, —OC(O)aryl, —OC(O)heterocyclyl, —OC(O)heteroaryl, —NHC 1 -C 20 alkyl, —NHC 2 -C 20 alkenyl, —NHC 2 -C 20 alkynyl, —NHcycloalkyl, —NHaryl, —NHheterocyclyl, —NHheteroaryl, —OC(O)NHC 1 -C 20 alkyl, —OC(O)NHC 2 -C 20 alkenyl, —OC(O)NHC 2 -C 20 alkynyl, —OC(O)NHcycloalkyl, —OC(O)NHaryl, —OC(O)NHheterocyclyl, —OC(O)NHheteroaryl, —OC(S)NHC 1 -C 20 alkyl, —OC(S)NHC 2 -C 20 alkenyl, —OC(S)NHC 2 -C 20 alkynyl, —OC(S)NHcycloalkyl, —OC(S)NHaryl, —OC(S)NHheterocyclyl, or —OC(S)NHheteroaryl;

R 19 and R 20 are each independently hydrogen, —C 1 -C 6 alkyl, —C 2 -C 6 alkenyl, —C 2 -C 20 alkynyl, —OH, —OC 1 -C 6 alkyl, —OC 2 -C 6 alkenyl, —OC 2 -C 6 alkynyl, —Ocycloalkyl, —OC(O)C 1 -C 6 alkyl, —OC(O)C 2 -C 6 alkenyl, —OC(O)C 2 -C 6 alkynyl, —OC(O)cycloalkyl, —OC(O)aryl, —OC(O)heterocyclyl, or —OC(O)heteroaryl;

or R 19 and R 20 taken together form a carbonyl or thiocarbonyl group;

R 21 is hydrogen, —C 1 -C 10 alkyl, —C 2 -C 10 alkenyl or —C 2 -C 10 alkynyl;

R 22 is —OH, —OC 1 -C 20 alkyl, —OC 2 -C 20 alkenyl, —OC 2 -C 20 alkynyl, —Ocycloalkyl, —OC(O)C 1 -C 20 alkyl, —OC(O)C 2 -C 20 alkenyl, —OC(O)C 2 -C 20 alkynyl, —OC(O)cycloalkyl, —OC(O)aryl, —OC(O)heterocyclyl, —OC(O)heteroaryl, —OC(O)NHC 1 -C 20 alkyl, —OC(O)NHC 2 -C 20 alkenyl, —OC(O)NHC 2 -C 20 alkynyl, —OC(O)NHcycloalkyl, —OC(O)NHaryl, —OC(O)NHheterocyclyl, —OC(O)NHheteroaryl, —OC(S)NHC 1 -C 20 alkyl, —OC(S)NHC 2 -C 20 alkenyl, —OC(S)NHC 2 -C 20 alkynyl, —OC(S)NHcycloalkyl, —OC(S)NHaryl, —OC(S)NHheterocyclyl, or —OC(S)NHheteroaryl;

or R 21 and R 22 taken together form a carbonyl group;

R 23 is hydrogen, —OH, —OC 1 -C 20 alkyl, —OC 2 -C 20 alkenyl, —OC 2 -C 20 alkynyl, —Ocycloalkyl, —OC(O)C 1 -C 20 alkyl, —OC(O)C 2 -C 20 alkenyl, —OC(O)C 2 -C 20 alkynyl, —OC(O)cycloalkyl, —OC(O)aryl, —OC(O)heterocyclyl, —OC(O)heteroaryl, —OC(O)NHC 1 -C 20 alkyl, —OC(O)NHC 2 -C 20 alkenyl, —OC(O)NHC 2 -C 20 alkynyl, —OC(O)NHcycloalkyl, —OC(O)NHaryl, —OC(O)NHheterocyclyl, —OC(O)NHheteroaryl, —OC(S)NHC 1 -C 20 alkyl, —OC(S)NHC 2 -C 20 alkenyl, —OC(S)NHC 2 -C 20 alkynyl, —OC(S)NHcycloalkyl, —OC(S)NHaryl, —OC(S)NHheterocyclyl, or —OC(S)NHheteroaryl;

R 24 is hydrogen, —OH, —OC 1 -C 20 alkyl, —OC 2 -C 20 alkenyl, —OC 2 -C 20 alkynyl, —Ocycloalkyl, —OC(O)C 1 -C 20 alkyl, —OC(O)C 2 -C 20 alkenyl, —OC(O)C 2 -C 20 alkynyl, —OC(O)cycloalkyl, —OC(O)aryl, —OC(O)heterocyclyl, —OC(O)heteroaryl, —OC(O)NHC 1 -C 20 alkyl, —OC(O)NHC 2 -C 20 alkenyl, —OC(O)NHC 2 -C 20 alkynyl, —OC(O)NHcycloalkyl, —OC(O)NHaryl, —OC(O)NHheterocyclyl, —OC(O)NHheteroaryl, —OC(S)NHC 1 -C 20 alkyl, —OC(S)NHC 2 -C 20 alkenyl, —OC(S)NHC 2 -C 20 alkynyl, —OC(S)NHcycloalkyl, —OC(S)NHaryl, —OC(S)NHheterocyclyl, or —OC(S)NHheteroaryl;

R 25 is hydrogen or —C 1 -C 10 alkyl;

R 26 and R 27 are each independently hydrogen, —C 1 -C 10 alkyl, —OH, or —OC 1 -C 10 alkyl;

wherein each alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocyclyl and heteroaryl is optionally substituted;

or a geometric isomer or stereoisomer thereof or a pharmaceutically acceptable salt thereof.

2. The method according to claim 1 , wherein the compound is a compound of formula (III):

wherein:

R 3 is hydrogen, —C 1 -C 6 alkyl or —C 2 -C 6 alkenyl;

R 4 and R 5 are each independently hydrogen, —C 1 -C 6 alkyl, —C 2 -C 6 alkenyl, —OH, —OC 1 -C 6 alkyl, —OC 2 -C 6 alkenyl, —OC(O)C 1 -C 6 alkyl, —OC(O)C 2 -C 6 alkenyl, —OC(O)aryl, —OC(O)heterocyclyl, —OC(O)heteroaryl, F, Cl, Br or I;

or R 4 and R 5 taken together form a double bond or are —O—;

R 6 is hydrogen, —C 1 -C 6 alkyl or —C 2 -C 6 alkenyl;

R 8 is hydrogen, —C 1 -C 6 alkyl or —C 2 -C 6 alkenyl;

R 13 and R 14 are each independently hydrogen or —C 1 -C 6 alkyl;

R a is hydrogen, —C 1 -C 20 alkyl, —C 2 -C 20 alkenyl, —C 2 -C 20 alkynyl, —C(O)C 2 -C 20 alkyl, —C(O)C 2 -C 20 alkenyl, —OC(O)C 2 -C 20 alkynyl, —C(O)cycloalkyl, —C(O)aryl, —C(O)heterocyclyl, —C(O)heteroaryl, —C(O)NHC 1 -C 20 alkyl, —C(O)NHC 2 -C 20 alkenyl, —C(O)NHC 2 -C 20 alkynyl, —C(O)NHcycloalkyl, —C(O)NHaryl, —C(O)NHheterocyclyl, —C(O)NHheteroaryl, —C(S)NHC 1 -C 20 alkyl, —C(S)NHC 2 -C 20 alkenyl, —C(S)NHC 2 -C 20 alkynyl, —C(S)NHcycloalkyl, —C(S)NHaryl, —C(S)NHheterocyclyl or —C(S)NHheteroaryl;

R b , R c , R d , R e and R f are each independently hydrogen, —C 1 -C 20 alkyl, —C 2 -C 20 alkenyl, —C 2 -C 20 alkynyl, —C(O)C 1 -C 20 alkyl, —C(O)C 2 -C 20 alkenyl, —OC(O)C 2 -C 20 alkynyl, —C(O)cycloalkyl, —C(O)aryl, —C(O)heterocyclyl, —C(O)heteroaryl, —C(O)NHC 1 -C 20 alkyl, —C(O)NHC 2 -C 20 alkenyl, —C(O)NHC 2 -C 20 alkynyl, —C(O)NHcycloalkyl, —C(O)NHaryl, —C(O)NHheterocyclyl, —C(O)NHheteroaryl, —C(S)NHC 1 -C 20 alkyl, —C(S)NHC 2 -C 20 alkenyl, —C(S)NHC 2 -C 20 alkynyl, —C(S)NHcycloalkyl, —C(S)NHaryl, —C(S)NHheterocyclyl or —C(S)NHheteroaryl;

wherein each alkyl, alkenyl, aryl, heterocyclyl and heteroaryl group is optionally substituted;

or a geometric isomer or stereoisomer or a pharmaceutically acceptable salt thereof.

3. The method according to claim 1 , wherein the compound is a compound of formula (IV):

wherein:

R 3 is hydrogen, —C 1 -C 6 alkyl or —C 2 -C 6 alkenyl;

R 4 and R 5 are each independently hydrogen, —C 1 -C 6 alkyl, —C 2 -C 6 alkenyl, —OH, —OC 1 -C 6 alkyl, —OC 2 -C 6 alkenyl, —OC(O)C 1 -C 6 alkyl, —OC(O)C 2 -C 6 alkenyl, —OC(O)aryl, —OC(O)heterocyclyl, —OC(O)heteroaryl, F, Cl, Br or I;

or R 4 and R 5 taken together form a double bond or are —O—;

R 6 is hydrogen, —C 1 -C 6 alkyl or —C 2 -C 6 alkenyl;

R 8 is hydrogen, —C 1 -C 6 alkyl or —C 2 -C 6 alkenyl;

R 10 is hydrogen;

R 11 is hydroxy, —OC 1 -C 20 alkyl, —OC 2 -C 20 alkenyl, —OC(O)C 2 -C 20 alkyl, —OC(O)C 2 -C 20 alkenyl, —OC(O)aryl, —OC(O)heterocyclyl, or —OC(O)heteroaryl;

or R 10 and R 11 taken together form a carbonyl group;

R 12′ is hydrogen, —C 1 -C 20 alkyl, —C 2 -C 20 alkenyl, —C(O)C 1 -C 20 alkyl, —C(O)C 2 -C 20 alkenyl, —C(O)aryl, —C(O)heterocyclyl or —C(O)heteroaryl;

R 13 and R 14 are each independently hydrogen or —C 1 -C 6 alkyl;

R 18′ is hydrogen, —C 1 -C 6 alkyl, —C 2 -C 6 alkenyl, —C(O)C 1 -C 6 alkyl, —C(O)C 2 -C 6 alkenyl, —C(O)aryl, —C(O)heterocyclyl or —C(O)heteroaryl;

R 19 and R 20 are each independently hydrogen, —OH, —OC 1 -C 6 alkyl, or —OC 2 -C 6 alkenyl;

or R 19 and R 20 taken together form a carbonyl group;

R 21 is hydrogen;

R 22 is hydroxy, —OC 1 -C 6 alkyl, —OC 2 -C 6 alkenyl, —OC(O)C 1 -C 6 alkyl, —OC(O)C 2 -C 6 alkenyl, —OC(O)aryl, —OC(O)heterocyclyl, or —OC(O)heteroaryl;

or R 21 and R 22 taken together form a carbonyl group;

wherein each alkyl, alkenyl, aryl, heterocyclyl or heteroaryl is optionally substituted;

or a geometric isomer or stereoisomer thereof or a pharmaceutically acceptable salt thereof.

4. The method according to claim 1 wherein R 1 and R 2 are each independently hydrogen, hydroxy, —OC 1 -C 6 alkyl, —OC 2 -C 6 alkenyl, —OC(O)C 1 -C 6 alkyl or —OC(O)C 2 -C 6 alkenyl; or R 1 and R 2 taken together form a carbonyl group.

5. The method according to claim 1 wherein R 4 and R 5 form a double bond or R 4 and R 5 are hydrogen or together are —O—.

6. The method according to claim 1 wherein R 8 is hydrogen or —C 1 -C 3 alkyl.

7. The method according to claim 1 wherein R 11 is hydroxy, —C 1 -C 20 alkyloxy, —C 2 -C 20 alkenyloxy, —OC(O)C 2 -C 20 alkyl or —OC(O)C 2 -C 20 alkenyl and R 12 is hydroxy, —C 1 -C 20 alkyloxy, —C 2 -C 20 alkenyloxy, —OC(O)C 1 -C 20 alkyl or —OC(O)C 2 -C 20 alkenyl.

8. The method according to claim 1 wherein R 13 and R 14 are each independently hydrogen or —C 1 -C 3 alkyl.

9. The method according to claim 1 wherein X is —O—.

10. The method according to claim 1 wherein R 19 and R 20 are each independently hydrogen, hydroxy, —OC 1 -C 3 alkyl, —OC 2 -C 3 alkenyl or R 19 and R 20 taken together form a carbonyl group and R 18 is hydroxy, —OC 1 -C 6 alkyl, —OC 2 -C 6 alkenyl, —OC(O)C 1 -C 6 alkyl or —OC(O)C 2 -C 6 alkenyl.

11. The method according to claim 1 wherein R 22 is hydroxy, —OC 1 -C 6 alkyl, —OC 2 -C 6 alkenyl, —OC(O)C 1 -C 6 alkyl or —OC(O)C 2 -C 6 alkenyl.

12. The method according to claim 1 wherein R 23 and R 24 are each hydroxy.

13. The method according to claim 1 wherein the compound of formula (II) is:

(12-tigloyl-13-(2-methylbutanoyl)-6,7-epoxy-4,5,9,12,13,20-hexahydroxy-1-tigliaen-3-one);

(12,13-di-(2-methylbutanoyl)-6,7-epoxy-4,5,9,12,13,20-hexahydroxy-tigliaen-3-one);

12-(dodeca-2,4,6-trienoyl)-13-(2-methylbutanoyl)-6,7-epoxy-4,5,9,12,13,20-hexahydroxy-1-tigliaen-3-one;

12-(deca-2,4-dienoyl)-6,7-epoxy-4, 5,9,12,13,20-hexahydroxy-1-tigliaen-3-one;

12,13-di-(2-methylbutanoyl)-1,2-2H-1,2,6,7-diepoxy-6-carboxy-4, 5,9,12,13-pentahydroxy-tigliaen-3-one; or

12,13-di-(2-methylbutanoyl)-5,20-di-acetoyl-4, 5,9,12,13,20-hexahydroxy-tigliaen-3-one.

14. The method according to claim 1 wherein the bacterial infection is caused by a bacterium from the genus Bacillus, Staphylococcus or Streptococcus.

15. The method according to claim 1 wherein the bacterial infection is caused by B. subtilis, B. anthracis, B. cereus, B. firmis, B. licheniformis, B. megaterium, B. pumilus, B. coagulans, B. pantothenticus, B. alvei, B. brevis, B. circubins, B. laterosporus, B. macerans, B. polymyxa, B. stearothermophilus, B. thuringiensis, B. sphaericus, S. aureus, S. epidermidis, S. haemolyticus, S. saprophyticus, S. pyrogenes, S. pneumoniae, S. alagactiae, S. dysgalactiae, S. equisimilis, S. equi, S. zooepidemicus, S. anginosus, S. salwarius, S. milleri, S. sanguis, S. mitior, S. mutans, S. faecalis, S. faecium, S. bovis, S. equinus, S. uberus, S. avium; Aerococcus spp., Gemella spp., Corynebacterium spp., Listeria spp., Kurthia spp., Lactobacillus spp., Erysipelothrix spp., Arachnia spp., Actinomyces spp., Propionibacterium spp., Rothia spp., Bifidobacterium spp., Clostridium spp., Eubacterium spp., Nocardia spp. or Mycobacterium spp.

16. The method according to claim 1 , wherein the nematode infection is caused by a nematode selected from the group consisting of Haemonchus contortus, Trichinella spiralis, H. placei, Bursaphelenchus xylophilus, Ostertagia circumcincta, O. ostertagi, Mecistocirrus digitatus, Trychostrongylus axei, Trichuris trichiura, T. vulpis, T. campanula, T. suis, T ovis, Bunostomum trigonocephalum, B. phleboyomum, Oesophagostomum columbianum, O. radiatum, Cooperia curticei, C. punctata, C. oncophora, C. pectinata, Strongyloides papillosus, Chabertia ovina, Ancylostoma duodenale, A. braziliense, A. tubaeforme, A. caninum, Ascaris lumbricoides, Enterobius vermicularis, E. gregorii, Paragonimus Westermani, Clonorchis sinensis, Fasciola hepatica, Taenia soliurn, T. saginata, Capillaria aerophila and Necator americanus , or a species of a genus selected from Trichuris, Baylisascaris, Aphelenchoides, Meliodogyne, Heterodera, Globodera, Nacobbus, Pratylenchus, Ditylenchus, Xiphinema, Longidorus, Trichodorus and Nematodirus.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2020
From: REDDELL, PAUL WARREN; GORDON, VICTORIA ANNE
To: QBIOTICS LIMITED
Reel/Frame 054693/0741 →
CHANGE OF NAME Recorded Dec 18, 2020
From: QBIOTICS LIMITED
To: QBIOTICS PTY LTD
Reel/Frame 054808/0035 →
Priority Claims (1)
AU 2005907278 · Dec 23, 2005 · national
Continuity (3)
Division 14084949 · Nov 20, 2013
Division 12158461
Related Publication 20160158187A1 · Jun 9, 2016